English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Psoriasis is immune-mediated chronic and recurrent, sistemic inflammatory skin disease, which is closely associated with oxidative stress (OS). Most characteristic skin lesions are red, scaly sharply demarcated, indurated plaques [1,2]. The etiological and genetic factors for psoriasis is yet not exactly known. But some of reasons like skin infection, drugs, trauma, emotional stress, smoking and alcohol are influences the clinical development of psoriasis [1-3]. In the previous studies, psoriasis is reported to be related to systemic diseases such as hyperlipidemia, hypertension, insulin resistance (IR), metabolic and cardiovascular diseases (CVD) [4-10]. Psoriatic inflammation leads to development of these diseases [5,10]. In fact, psoriasis has been shown to be an independent risk factor for these systemic diseases [4,10]. The increased incidence of cardio-metabolic diseases in psoriasis is caused by underlying systemic inflammation together with ABSTRACT

Investigation of adropin and IMA levels in psoriasis and their relation to duration and severity of disease